SCHEMBL16236189

SCHEMBL16236189

CC(CC(C)SC(=O)c1cccc(Cl)c1)SC(=O)c1cccc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.47
HPGD P15428 4/20 0.47
SLC6A2 P23975 5/20 0.47
SLC6A3 Q01959 4/20 0.47
CHRNA1 P02708 2/20 0.47
CHRNG P07510 2/20 0.47
CHRNB1 P11230 2/20 0.47
CHRNB2 P17787 2/20 0.47
CHRNB4 P30926 2/20 0.47
SLC6A4 P31645 2/20 0.47
CHRNA3 P32297 2/20 0.47
CHRNA4 P43681 2/20 0.47
CHRND Q07001 2/20 0.47
ITGA5 P08648 1/20 0.47
CYP2C19 P33261 1/20 0.47
HRH1 P35367 1/20 0.47
CHRNA7 P36544 1/20 0.47
OPRK1 P41145 1/20 0.47
KCNH2 Q12809 1/20 0.47
CYP2B6 P20813 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16235586 0.88 HPGD (0.48) PARP1HPGDSLC6A2SLC6A3CHRNA1
SCHEMBL16235711 0.88 TRPV1 (0.42) PARP1HPGDSLC6A2SLC6A3CHRNA1
SCHEMBL16239069 0.86 HPGD (0.42) PARP1HPGDSLC6A2SLC6A3CHRNA1
SCHEMBL19244488 0.85 HPGD (0.43) PARP1HPGDSLC6A2SLC6A3CHRNA1
SCHEMBL16236318 0.82 HPGD (0.39) PARP1HPGDSLC6A2SLC6A3CHRNA1
SCHEMBL16236057 0.81 HPGD (0.44) PARP1HPGDSLC6A2SLC6A3CHRNA1
SCHEMBL18113108 0.81 MAPT (0.43) PARP1HPGDSLC6A2SLC6A3CHRNA1
SCHEMBL16250754 0.79 GPR139 (0.45) HPGDHRH1KCNH2ALDH1A1SMN1; SMN2
SCHEMBL16236134 0.79 GPR139 (0.45) HPGDHRH1KCNH2ALDH1A1SMN1; SMN2
SCHEMBL18113259 0.78 HPGD (0.45) PARP1HPGDSLC6A2SLC6A3CHRNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005860-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2018-06-26 US disclosed
EP-2997049-B1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA SRL (IT) 2017-08-23 EP disclosed
US-20170166667-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-06-15 US disclosed
US-9644051-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-05-09 US disclosed
US-20160090428-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia, s.r.l. (IT) 2016-03-31 US disclosed
EP-2997049-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2016-03-23 EP disclosed
WO-2014184289-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2014-11-20 WO disclosed
EP-2803679-A1 Catalyst components for the polymerization of olefins Basell Poliolefine Italia S.r.l. (IT) 2014-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005860-B2 Catalyst components for the polymerization of olefins OXER1, OXSR1, NR0B2 PARP1 1333/4885HPGD 2211/4885SLC6A2 3401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.